BRCA PLUS ONCOKITDX
Mexico·Clase II·III. DIAGNOSTIC AGENTS·LABORATORIOS LICON, S.A.·Registered April 16, 2019BRCA PLUS ONCOKITDX HA SIDO DISEÑADO PARA IDENTIFICAR LAS MUTACIONES PUNTUALES Y PEQUEÑAS INSERCIONES Y DELECIONES EN LAS REGIONES CODIFICANTES, ASÍ COMO LOS SITIOS DE SPLICING DE LOS GENES BRCA1 Y BRCA2. ESTE KIT PERMITE DETECTAR GRANDES DELECIONES Y DU
BRCA PLUS ONCOKITDX HAS BEEN DESIGNED TO IDENTIFY POINT MUTATIONS AND SMALL INSERTIONS AND DELETIONS IN CODING REGIONS AS WELL AS SPLICING SITES OF BRCA1 AND BRCA2 GENES. THIS KIT ALLOWS TO DETECT LARGE DELETIONS AND DU
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- KITS DE REACTIVOS PARA EL ANÁLISIS GENÉTICO MOLECULAR DE LOS GENES BRCA1, BRCA2 Y FARMACOGENÉTICA AS
- Trade Name (English)
- REAGENT KITS FOR MOLECULAR GENETIC ANALYSIS OF BRCA1, BRCA2 AND AS PHARMACOGENETICS GENES
- Analysis ID
- 805R2019 SSA
- Registration Date
- April 16, 2019
- Name (Spanish)
- LABORATORIOS LICON, S.A.
- Name (English)
- LABORATORIOS LICON, S.A.
Access comprehensive regulatory information for BRCA PLUS ONCOKITDX (BRCA PLUS ONCOKITDX) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 805R2019 SSA and manufactured by LABORATORIOS LICON, S.A.. The device was registered on April 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.